Apply for active substance renewal by the deadlines to keep products on the GB market Under the GB Biocidal Products Regulation (GB BPR), active substance approvals will expire unless a renewal application is submitted at least 550 days before their expiry date. The 550-day deadlines are coming up for the following active substance/product type combinations under GB BPR. 29 May 2025 - 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (propiconazole) (CAS 60207-90-1 EC 262-104-4) in product type 7
- 3-iodo-2-propynylbutylcarbamate (IPBC) (CAS 55406-53-6 EC 259-627-5) in product type 13
- 5-chloro-2-(4-chlorphenoxy)phenol (DCPP) (CAS 3380-30-1 EC 429-290-0) in product types 1, 2 and 4
- Potassium (E,E)-hexa-2,4-dienoate (potassium sorbate) (CAS 24634-61-5 EC 246-376-1) in product type 8
27 August 2025 - Bacillus thuringiensis subsp. kurstaki, strain ABTS-351 (CAS N/A EC N/A) in product type 18
27 August 2026 - Citric acid (CAS 77-92-9 EC 201-069-1) in product type 2
- α-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (cyfluthrin) (CAS 68359-37-5 EC 269-855-7) in product type 18
Any person, company or task force/consortium can support an active substance/product type combination for renewal â it doesnât have to be the original supporter.
Check the GB Article 95 List to see who the original supporters were If any of these active substance/product type combinations are important to you, consider contacting your supplier to let them know. If a renewal application is not submitted for the above active substance/product type combinations under GB BPR, the approvals will expire. This means the active substances will no longer be able to be used in biocidal products of the relevant product types. In addition articles treated with such products will no longer be able to be placed on the market. Take action to keep your active substance in the GB Review Programme The active substance/product type combinations listed have been successfully notified into the GB Review Programme following an open invitation. The next step is for a full active substance dossier to be submitted to HSE by the following deadline: 23 May 2025 - Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents (redefined from pyrethrins and pyrethroids and Chrysanthemum cinerariaefolium, ext.) (CAS 89997-63-7 EC 289-699-3) in product types 18 and 19
Only the person, company or task force/consortium that successfully notified the active substance/product type combinations listed can submit a dossier.
If any of these active substance/product type combinations are important to you, consider contacting the notifier to let them know. You may even be able to join them in supporting the active substance. Check the list of successful notifiers If a dossier is not submitted by the deadline, these active substance/product type combinations will be subject to a GB non-approval decision. This means the active substance will no longer be able to be used in biocidal products of the relevant product types. In addition articles treated with such products will no longer be able to be placed on the market. HSE will provide separate updates on these where relevant. | 
